This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Handicapping Key Earnings Reports

Earnings Reports for Wednesday:

Pepsico (PEP) ($70.34): Has a buy rating according to ValuEngine with a slightly elevated P/E. PEP is above its 200-day SMA at $68.03. The stock reached a multi-year high at $73.66 on Aug. 27. The weekly chart is negative with the 200-week SMA at $62.97. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

American Express (AXP) ($57.59): Has a buy rating according to ValuEngine with a reasonable P/E and is above its 200-day SMA at $55.83. The stock set its 2012 high at $61.42 on May 2 and a 2012 low at $53.18 on June 1. The weekly chart profile shifts to negative on a close this week below its five-week modified moving average at $57.80. The 200-week SMA is $42.21. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Earnings Reports for Thursday:

Google Inc (GOOG - Get Report) ($740.98): Has been upgraded to buy from hold this morning according to ValuEngine. The stock has an elevated P/E and is well above its 200-day SMA at $630.83. Google set an all-time-high at $774.38 on Oct. 5 and then was downgraded to hold from buy. The weekly chart profile is positive but overbought with the 200-week SMA at $538.51. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Travelers Companies (TRV - Get Report) ($69.79): Has a buy rating according to ValuEngine with a reasonable P/E. The stock is above its 200-day SMA at $62.34. TRV set a multi-year high at $70.00 on Oct 4. The weekly chart profile is positive but overbought with the 200-week SMA at $53.34. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Morgan Stanley (MS) ($17.31): Has a hold rating according to ValuEngine with a slightly elevated P/E. The stock is above its 200-day SMA at $16.35. MS set its 2012 high at $21.19 on March 26 then had its 2012 low at $12.66 on June 4. The weekly chart is positive but overbought with the 200-week SMA at $23.37. Investors and traders should employ a "buy-and-trade" strategy between the value level and risky level.

Microsoft Corp (MSFT - Get Report) ($29.51): Has a buy rating according to ValuEngine with a favorable P/E and is below its 200-day SMA at $30.34. The stock set its 2012 high at $32.95 on March 16 and 2012 low at $28.32 on June 4. The weekly chart is negative with the 200-week SMA at $26.36. Investors and traders should book profits on strength to my annual pivot at $29.58 then employ a "buy-and-trade" strategy between the value level and risky level.

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
GOOG $537.90 0.00%
MCD $97.80 0.00%
MSFT $48.66 0.00%
TRV $102.12 0.00%
VZ $50.41 0.00%

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs